Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirotoshi Hoshiyama

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 6, 2023
[Pharmacological characteristics and clinical study results of the first RAS inhibitor sotorasib (LUMAKRAS<sup>®</sup>) for non-small cell lung cancer with KRAS G12C mutation]Hirotoshi Hoshiyama
Nucleic Acids Research|December 13, 2007
Quantitative telomeric overhang determination using a double-strand specific nucleaseYong Zhao, Hirotoshi Hoshiyama, Jerry W Shay, et al.
EMBO Reports|December 24, 2005
The involvement of the Mre11/Rad50/Nbs1 complex in the generation of G-overhangs at human telomeresWeihang Chai, Agnel J Sfeir, Hirotoshi Hoshiyama, et al.
Journal of Biomolecular Screening|September 30, 2011
Development of methods for quantitative comparison of pooled shRNAs by mass sequencingHirotoshi Hoshiyama, Jun Tang, Kimberly Batten, et al.
Neoplasia (New York, N.Y.)|February 27, 2013
The roles of telomerase in the generation of polyploidy during neoplastic cell growthAgni Christodoulidou, Christina Raftopoulou, Maria Chiourea, et al.
BMC Genomics|October 22, 2016
Impaired telomere maintenance in Alazami syndrome patients with LARP7 deficiencyBrody Holohan, Wanil Kim, Tsung-Po Lai, et al.
Lung Cancer (Amsterdam, Netherlands)|December 16, 2019
Real-world effectiveness and safety of nivolumab in patients with non-small cell lung cancer: A multicenter retrospective observational study in JapanRyo Morita, Kyoichi Okishio, Junichi Shimizu, et al.
ESMO Open|July 22, 2020
Nivolumab treatment of elderly Japanese patients with non-small cell lung cancer: subanalysis of a real-world retrospective observational study (CA209-9CR)Kyoichi Okishio, Ryo Morita, Junichi Shimizu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 6, 2023
[Pharmacological characteristics and clinical study results of the first RAS inhibitor sotorasib (LUMAKRAS<sup>®</sup>) for non-small cell lung cancer with KRAS G12C mutation]Hirotoshi Hoshiyama
Nucleic Acids Research|December 13, 2007
Quantitative telomeric overhang determination using a double-strand specific nucleaseYong Zhao, Hirotoshi Hoshiyama, Jerry W Shay, et al.
EMBO Reports|December 24, 2005
The involvement of the Mre11/Rad50/Nbs1 complex in the generation of G-overhangs at human telomeresWeihang Chai, Agnel J Sfeir, Hirotoshi Hoshiyama, et al.
Journal of Biomolecular Screening|September 30, 2011
Development of methods for quantitative comparison of pooled shRNAs by mass sequencingHirotoshi Hoshiyama, Jun Tang, Kimberly Batten, et al.
Neoplasia (New York, N.Y.)|February 27, 2013
The roles of telomerase in the generation of polyploidy during neoplastic cell growthAgni Christodoulidou, Christina Raftopoulou, Maria Chiourea, et al.
BMC Genomics|October 22, 2016
Impaired telomere maintenance in Alazami syndrome patients with LARP7 deficiencyBrody Holohan, Wanil Kim, Tsung-Po Lai, et al.
Lung Cancer (Amsterdam, Netherlands)|December 16, 2019
Real-world effectiveness and safety of nivolumab in patients with non-small cell lung cancer: A multicenter retrospective observational study in JapanRyo Morita, Kyoichi Okishio, Junichi Shimizu, et al.
ESMO Open|July 22, 2020
Nivolumab treatment of elderly Japanese patients with non-small cell lung cancer: subanalysis of a real-world retrospective observational study (CA209-9CR)Kyoichi Okishio, Ryo Morita, Junichi Shimizu, et al.
Pageof 1